Matches in Nanopublications for { ?s ?p "DDI between Rizatriptan and Moclobemide - The MAO inhibitor, moclobemide, may decrease the metabolism and clearance of the serotonin 5-HT receptor agonist, rizatriptan. Concomitant therapy is contraindicated."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.